Hartford Investment Management Co. Has $28.78 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Hartford Investment Management Co. lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 56,893 shares of the healthcare conglomerate’s stock after selling 1,226 shares during the quarter. UnitedHealth Group accounts for approximately 0.9% of Hartford Investment Management Co.’s portfolio, making the stock its 15th biggest holding. Hartford Investment Management Co.’s holdings in UnitedHealth Group were worth $28,780,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Gladstone Institutional Advisory LLC grew its stake in UnitedHealth Group by 1.3% during the fourth quarter. Gladstone Institutional Advisory LLC now owns 13,863 shares of the healthcare conglomerate’s stock worth $7,013,000 after purchasing an additional 175 shares during the period. Perissos Private Wealth Management LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $259,000. Capital Advisors Inc. OK boosted its stake in UnitedHealth Group by 13.8% during the fourth quarter. Capital Advisors Inc. OK now owns 75,974 shares of the healthcare conglomerate’s stock worth $38,432,000 after acquiring an additional 9,197 shares in the last quarter. Certuity LLC increased its stake in UnitedHealth Group by 24.1% in the fourth quarter. Certuity LLC now owns 2,825 shares of the healthcare conglomerate’s stock valued at $1,429,000 after purchasing an additional 548 shares in the last quarter. Finally, Community Financial Services Group LLC boosted its position in shares of UnitedHealth Group by 5.2% during the 4th quarter. Community Financial Services Group LLC now owns 12,937 shares of the healthcare conglomerate’s stock worth $6,544,000 after purchasing an additional 634 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $533.99 on Wednesday. The company has a market cap of $491.42 billion, a price-to-earnings ratio of 34.45, a PEG ratio of 1.45 and a beta of 0.61. The business’s 50 day simple moving average is $527.67 and its 200 day simple moving average is $564.22. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period in the previous year, the business posted $5.83 EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Company insiders own 0.33% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on UNH. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Stephens lifted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. TD Cowen raised their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Piper Sandler dropped their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.